Mustang Bio, Inc(NASDAQ:MBIO) 
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chim...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.22
H 1.24
L 1.15
C 1.21
V 95,028
10EMA 1.21
20EMA 1.21
60EMA 1.21
120EMA 1.21
250EMA 1.21